Weeks Medical Center Critical Access Hospital (Medicare Certified) Location: 173 Middle Street, Lancaster, New Hampshire 03584 Ratings: Phone: (603) 788-4911 |
News Archive
The first speech recognition aid to give a voice to people with severe speech impairment is the flagship technology on display today [19 November] at the launch of the University of Sheffield's new Centre for Assistive Technology and Connected Healthcare.
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin.
Breast cancer that spreads to other organs is extremely difficult to treat. Doctors can buy patients time, but a cure remains elusive. Now, researchers at Washington University School of Medicine in St. Louis have shown that human breast tumors transplanted into mice are excellent models of metastatic cancer and could be valuable tools in the search for better treatments.
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRAâ„¢ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
› Verified 2 days ago